The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Innoviva Strategic Opportunities Llc since 2021.
This trader's CIK number is 1842875.
At the time of last reporting, Innoviva Strategic Opportunities Llc was the Officer of Entasis Therapeutics Holdings Inc.. (stock ticker symbol ETTX).
Also see all insider trading activities at Entasis Therapeutics Holdings Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | ARMP | 9,000,000 | $45,000,000 | 0 | $0 | 0 | $0 |
| 2021 | ARMP | 7,365,969 | $24,000,004 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2022 | ETTX | 19,270,476 | $42,395,046 | 0 | $0 | 0 | $0 |
| 2021 | ETTX | 10,000,000 | $20,000,000 | 0 | $0 | 0 | $0 |
1. Armata Pharmaceuticals, Inc. (ARMP)
2. Entasis Therapeutics Holdings Inc. (ETTX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-03-31 | ARMP | Buy | 5,385,208 | 5.00 | 26,926,040 |
| 2022-02-09 | ARMP | Buy | 3,614,792 | 5.00 | 18,073,960 |
| 2021-10-29 | ARMP | Buy | 1,212,122 | 3.30 | 4,000,002 |
| 2021-03-17 | ARMP | Buy | 4,285,935 | 3.25 | 13,929,288 |
| 2021-01-26 | ARMP | Buy | 1,867,912 | 3.25 | 6,070,714 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2022-07-11 | ETTX | Buy | 7,598,814 | 2.20 | 16,717,390 |
| 2022-07-08 | ETTX | Buy | 11,671,662 | 2.20 | 25,677,656 |
| 2021-06-11 | ETTX | Buy | 6,268,975 | 2.00 | 12,537,950 |
| 2021-05-03 | ETTX | Buy | 3,731,025 | 2.00 | 7,462,050 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Innoviva Strategic Opportunities Llc (Officer of Entasis Therapeutics Holdings Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.